KMID : 0895820100200040197
|
|
Journal of Oriental Rehabilitation Medicine 2010 Volume.20 No. 4 p.197 ~ p.213
|
|
Clinical Trial of Taeeumjowui -Tang(Taiyintiaowei-tang) on Obese Patients - Randomized, Double Blind, Placebo-Controlled Study -
|
|
Lee Ji-Eun
Song Yun-Kyung Lim Hyung-Ho
|
|
Abstract
|
|
|
Objectives :The clinical trial was designed to investigate the safety and effects of Taeeumjowui-tang(Taiyintiaowei-tang) extracts on the change of the weight, body compositions, serum in obese patients.
Methods :This study was a 12-weeks, randomized, double blind, placebo-controlled clinical trial. Patients with a body mass index of either greater than 30 kg/m2 or between 27 and 30 kg/m2 with controlled hypertension, diabetes, hyperlipidemia were considered eligible. Participants of 41 obese patients were randomized either to Taeeumjowui-tang(Taiyintiaowei-tang)(23) or placebo(18). After 12 weeks of treatment, we measured anthropometric factors(weight, height, waist circumference, BMI(body mass index) etc.), abdominal fat area by CT(computed tomography) scanning, serum lipid(total cholesterol, tryglyceride, HDL-cholesterol, LDL-cholesterol), blood level of variety(AST, ALT, BUN, creatinine etc.). Adverse events also evaluated.
Results :After 12 weeks of treatment mean weight, waist-circumference, total cholesterol, LDL-cholesterol and score of KEAT-26 were significant changed in Taeeumjowui-tang (Taiyintiaowei-tang). There were no serious adverse events in either groups.
Conclusions :There were limited in this study that it conducted within a short period of 12 weeks. but its weight and WC(waist circumference), WHR(waist hip ratio), total cholesterol, LDL-cholesterol and score of KEAT-26 loss effect was significant and it had few adverse events.
|
|
KEYWORD
|
|
Obesity, Taeeumjowui-tang, Taiyintiaowei-tang, Efficacy, Safety
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|